Pub Date : 2023-04-01DOI: 10.4103/jras.jras_107_23
A. Balkrishna
{"title":"World Herbal Encyclopedia","authors":"A. Balkrishna","doi":"10.4103/jras.jras_107_23","DOIUrl":"https://doi.org/10.4103/jras.jras_107_23","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"174 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123204468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.4103/jras.jras_102_23
Indroneel Das, Krutika K. Mehra, V. Reddy, Eeshana Ish, Ramayi Kayina
The vision, foresight and guidance of the Hon’ble Prime Minister, proxied strongly by the mentions of the Ayush sector and the Ministry of Ayush in ‘Mann Ki Baat’ have coincided with the rapid growth & development of the Ayush sector in India, and its increased demand across the globe. The two are hypothesized to have coincided because of a potential direct correlation between the impact and credibility of the Hon’ble Prime Minister’s highlights of Ayush through ‘Mann Ki Baat’, which have translated into a metamorphosis of the sector as a multiplier effect of the number of people & institutions following the commentary of ‘Mann Ki Baat’, as well as the credibility & coverage of ‘Mann Ki Baat’. The growth seen in Ayush industry (manufacturing & services), research & development, public health initiatives & demand, global traction, investment interest, and regulatory frameworks strongly support this correlation, especially when seen considering the specific initiatives, events, and developments of the Ayush sector which have been highlighted in a particular timeline by the Hon’ble PM, show a parallel upsurge in that specific (or related) sub-sector of Ayush. The objective of the current study is to Analyze & establish the impact of Ayush related highlights & mentions of the Hon’ble Prime Minister on ‘Mann Ki Baat’, on the Ayush sector. In the current work the Objective analysis of ongoing initiatives, events of Ministry of Ayush, supported by Ayush Strategic Policy & Facilitation Bureau (Invest India). Knowledge derived from/data sourced from the following: 1. Ayush Strategic Policy & Facilitation Bureau (Invest India) knowledge sources & investigations 2. Ayush Strategic Policy & Facilitation Bureau (Invest India) industry interaction & feedback 3. Internal assessments & data from Ministry of Ayush 4. Startup India/Department for Promotion of Industry &Internal Trade databases 5. RIS Report on “Ayush Sector in India: Prospects & Challenges” 6. RIS Report on “Ayush Exports: Regulatory Opportunities & Challenges in Key Markets” 7. Invest India (Strategic Investment Research Unit) Report on “Think Holistic Health, Think India” 8. All India Institute of Ayurveda knowledge sourcesObservations and developments captured from the above have been juxtaposed thematically with domain-specific announcements by Hon’ble Prime Minister through ‘Mann Ki Baat’ and impacts have been studied in short-term (between 6 months to 1 year of announcement/attention given to a particular theme in Ayush) and sustainable long-term trends that have henceforth developed in the sector (as evidenced by Govt. data and ‘Mann Ki Baat’ announcements, from 2014 to 2023)Evidences from the listed methods &sources suggest a strong direct correlation between specific instances of Hon’ble Prime Minister’s coverage and/or mention of Ayush in ‘Mann Ki Baat’ (specific instances in Annexure 1) and a sustainable upsurge in the related domain Wof Ayush. Moreover, the overall synergistic impact o
在“Mann Ki Baat”中提到的阿尤什部门和阿尤什部强烈代表了总理的远见,远见和指导,这与印度阿尤什部门的快速增长和发展以及全球需求的增加相吻合。这两者被假设是一致的,因为总理阁下通过“Mann Ki Baat”对Ayush的强调的影响和可信度之间存在潜在的直接关联,这已经转化为该部门的蜕变,作为“Mann Ki Baat”评论之后的人员和机构数量的乘数效应,以及“Mann Ki Baat”的可信度和覆盖率。阿尤什工业(制造和服务)、研发、公共卫生倡议和需求、全球牵引力、投资兴趣和监管框架的增长有力地支持了这种相关性,特别是考虑到阿尤什行业的具体举措、事件和发展,这些都是由总理在特定时间点强调的,表明阿尤什的特定(或相关)子行业也出现了平行增长。当前研究的目的是分析和确定与阿尤什相关的亮点和提及“Mann Ki Baat”总理对阿尤什部门的影响。在目前的工作中,在阿尤什战略政策和促进局(投资印度)的支持下,对阿尤什部正在进行的倡议和事件进行客观分析。来自以下方面的知识/数据:阿尤什战略政策与促进局(印度投资)知识来源和调查阿尤什战略政策与促进局(印度投资)行业互动与反馈来自阿尤什部的内部评估和数据启动印度/促进工业和内部贸易部门数据库RIS关于“印度阿尤什行业:前景与挑战”的报告RIS报告“阿尤什出口:关键市场的监管机遇与挑战”投资印度(战略投资研究单位)关于"思考整体健康,思考印度"的报告所有印度阿育吠陀研究所知识来源从上述观察和发展中获得的主题与总理通过“Mann Ki Baat”发布的特定领域公告并列,并在短期(6个月至1年的公告/对阿尤什特定主题的关注)和可持续的长期趋势中研究了影响,这些趋势从此在该行业发展(如政府数据和“Mann Ki Baat”公告所证明的那样)。从2014年到2023年)所列出的方法和来源的证据表明,在“Mann Ki Baat”(附件1中的具体实例)中,Hon ' ble总理的报道和/或提到Ayush的具体实例与相关领域的持续高涨之间存在着强烈的直接关联。此外,“Mann Ki Baat”在2014-2023年期间的整体协同影响提供了多个数据点(接近50个),其中“Mann Ki Baat”中提到的数据点与该行业近期的积极需求和/或发展相吻合,并形成了该行业的长期趋势。因此,可以得出的结论是,总理先生通过他的愿景和对“Mann Ki Baat”的阿尤什部门的强调,已经引起并催化了阿尤什部门在国内和全球的增长。
{"title":"Powering the Growth of India’s Ayush Sector","authors":"Indroneel Das, Krutika K. Mehra, V. Reddy, Eeshana Ish, Ramayi Kayina","doi":"10.4103/jras.jras_102_23","DOIUrl":"https://doi.org/10.4103/jras.jras_102_23","url":null,"abstract":"The vision, foresight and guidance of the Hon’ble Prime Minister, proxied strongly by the mentions of the Ayush sector and the Ministry of Ayush in ‘Mann Ki Baat’ have coincided with the rapid growth & development of the Ayush sector in India, and its increased demand across the globe. The two are hypothesized to have coincided because of a potential direct correlation between the impact and credibility of the Hon’ble Prime Minister’s highlights of Ayush through ‘Mann Ki Baat’, which have translated into a metamorphosis of the sector as a multiplier effect of the number of people & institutions following the commentary of ‘Mann Ki Baat’, as well as the credibility & coverage of ‘Mann Ki Baat’. The growth seen in Ayush industry (manufacturing & services), research & development, public health initiatives & demand, global traction, investment interest, and regulatory frameworks strongly support this correlation, especially when seen considering the specific initiatives, events, and developments of the Ayush sector which have been highlighted in a particular timeline by the Hon’ble PM, show a parallel upsurge in that specific (or related) sub-sector of Ayush. The objective of the current study is to Analyze & establish the impact of Ayush related highlights & mentions of the Hon’ble Prime Minister on ‘Mann Ki Baat’, on the Ayush sector. In the current work the Objective analysis of ongoing initiatives, events of Ministry of Ayush, supported by Ayush Strategic Policy & Facilitation Bureau (Invest India). Knowledge derived from/data sourced from the following: 1. Ayush Strategic Policy & Facilitation Bureau (Invest India) knowledge sources & investigations 2. Ayush Strategic Policy & Facilitation Bureau (Invest India) industry interaction & feedback 3. Internal assessments & data from Ministry of Ayush 4. Startup India/Department for Promotion of Industry &Internal Trade databases 5. RIS Report on “Ayush Sector in India: Prospects & Challenges” 6. RIS Report on “Ayush Exports: Regulatory Opportunities & Challenges in Key Markets” 7. Invest India (Strategic Investment Research Unit) Report on “Think Holistic Health, Think India” 8. All India Institute of Ayurveda knowledge sourcesObservations and developments captured from the above have been juxtaposed thematically with domain-specific announcements by Hon’ble Prime Minister through ‘Mann Ki Baat’ and impacts have been studied in short-term (between 6 months to 1 year of announcement/attention given to a particular theme in Ayush) and sustainable long-term trends that have henceforth developed in the sector (as evidenced by Govt. data and ‘Mann Ki Baat’ announcements, from 2014 to 2023)Evidences from the listed methods &sources suggest a strong direct correlation between specific instances of Hon’ble Prime Minister’s coverage and/or mention of Ayush in ‘Mann Ki Baat’ (specific instances in Annexure 1) and a sustainable upsurge in the related domain Wof Ayush. Moreover, the overall synergistic impact o","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116472418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.4103/jras.jras_164_22
D. Makhija, P. Borkar, Priti R Desai, Renu Singh, R. Singhal
BACKGROUND: Rheumatoid arthritis (RA) is a chronic, progressive, systemic autoimmune disease primarily affecting the synovial joints. Clinical symptoms of RA are similar to Amavata- a disease mentioned in Ayurveda. As per the Ayurveda classical texts, the formation and deposition of Ama (biotoxin) play a significant role in the pathogenesis of Amavata (RA). Hence, Deepana (appetite stimulant) & Ama-pachana (interventions that digest the biotoxins) can be first line of treatment for managing RA. Being Deepana and Pachana, Pathyadi Churna and Trikatu Churna can mitigate the Ama, prevent its genesis in the body, and thereby break down the pathogenesis of RA. Both formulations have anti-inflammatory and analgesic action which is supportive while treating RA. The present study will compare the efficacy of Pathyadi Churna and Trikatu Churna in managing RA. MATERIALS AND METHODS: It will be a randomized, parallel-group comparative trial with a sample size of 110 participants. Patients of any gender aged 18 to 65 years diagnosed with Rheumatoid arthritis based on American College of Rheumatology (ACR) 2010 criteria and presenting with Sama clinical features of Amavata will be enrolled in the study. Participants will be divided randomly into two groups. In group I, Pathyadi Churna, and Group II, Trikatu Churna will be administered in 3 gm and 1 gm, respectively, twice daily after food with lukewarm water for four weeks. The efficacy of the study interventions will be assessed through the changes in Disease Activity Score 28 (DAS28) and Ayurvedic disease-specific parameters from baseline. CONCLUSION: The study will help generate evidence regarding the efficacy of Pathyadi Churna and Trikatu Churna in managing RA.
背景:类风湿性关节炎(RA)是一种慢性、进行性、系统性自身免疫性疾病,主要影响滑膜关节。类风湿性关节炎的临床症状类似于阿育吠陀中提到的一种疾病——阿玛瓦塔。根据阿育吠陀经典文献,Ama(生物毒素)的形成和沉积在Amavata (RA)的发病机制中起着重要作用。因此,Deepana(食欲刺激剂)和Ama-pachana(消化生物毒素的干预措施)可以作为治疗类风湿性关节炎的一线治疗方法。作为Deepana和Pachana, Pathyadi Churna和Trikatu Churna可以减轻Ama,防止其在体内发生,从而打破RA的发病机制。两种配方都具有抗炎和镇痛作用,在治疗类风湿性关节炎时具有支持作用。本研究将比较Pathyadi Churna和Trikatu Churna治疗RA的疗效。材料和方法:这将是一项随机、平行组比较试验,样本量为110名参与者。根据美国风湿病学会(American College of Rheumatology, ACR) 2010标准诊断为类风湿关节炎的年龄在18至65岁之间的任何性别的患者,并呈现Amavata的Sama临床特征,都将被纳入研究。参与者将被随机分为两组。第一组为Pathyadi Churna,第二组为Trikatu Churna,分别为3克和1克,每天两次,餐后用温水给药,持续四周。研究干预措施的有效性将通过疾病活动评分28 (DAS28)和阿育吠陀疾病特异性参数的基线变化来评估。结论:本研究将有助于提供证据,证明百加地和Trikatu百加地治疗类风湿性关节炎的疗效。
{"title":"Efficacy of Pathyadi Churna and Trikatu Churna in the management of Amavata (rheumatoid arthritis): Protocol for a comparative clinical study","authors":"D. Makhija, P. Borkar, Priti R Desai, Renu Singh, R. Singhal","doi":"10.4103/jras.jras_164_22","DOIUrl":"https://doi.org/10.4103/jras.jras_164_22","url":null,"abstract":"BACKGROUND: Rheumatoid arthritis (RA) is a chronic, progressive, systemic autoimmune disease primarily affecting the synovial joints. Clinical symptoms of RA are similar to Amavata- a disease mentioned in Ayurveda. As per the Ayurveda classical texts, the formation and deposition of Ama (biotoxin) play a significant role in the pathogenesis of Amavata (RA). Hence, Deepana (appetite stimulant) & Ama-pachana (interventions that digest the biotoxins) can be first line of treatment for managing RA. Being Deepana and Pachana, Pathyadi Churna and Trikatu Churna can mitigate the Ama, prevent its genesis in the body, and thereby break down the pathogenesis of RA. Both formulations have anti-inflammatory and analgesic action which is supportive while treating RA. The present study will compare the efficacy of Pathyadi Churna and Trikatu Churna in managing RA. MATERIALS AND METHODS: It will be a randomized, parallel-group comparative trial with a sample size of 110 participants. Patients of any gender aged 18 to 65 years diagnosed with Rheumatoid arthritis based on American College of Rheumatology (ACR) 2010 criteria and presenting with Sama clinical features of Amavata will be enrolled in the study. Participants will be divided randomly into two groups. In group I, Pathyadi Churna, and Group II, Trikatu Churna will be administered in 3 gm and 1 gm, respectively, twice daily after food with lukewarm water for four weeks. The efficacy of the study interventions will be assessed through the changes in Disease Activity Score 28 (DAS28) and Ayurvedic disease-specific parameters from baseline. CONCLUSION: The study will help generate evidence regarding the efficacy of Pathyadi Churna and Trikatu Churna in managing RA.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124954420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.4103/jras.jras_168_22
Savita Gopod, Sujata P. Dhoke, K. Anumol, P. Kumar, Soumya Sheji, Manisha Talekar, L. Sharma, Arunabh Tripathi, S. Ota
BACKGROUND: In the classical text of Ayurveda, formulations Shatavari Gudam (SG) and Triphala Kashaya (TK) are indicated to treat Shwetapradara. The disease Shwetapradara can be correlated to leucorrhoea based on the similar symptom, painless, white-colored discharge from the vagina. SG is a formulation containing Shatavari (Asparagus racemosus) as a main ingredient. Several studies indicate Shatavari as a tonic for reproductive tract-related diseases. The external use of Triphala has anti-inflammatory, antiseptic, and anti-bacterial actions. The present article is a clinical study protocol on the efficacy and safety evaluation of SG and TK in leucorrhoea (Shwetapradara). MATERIALS AND METHODS: It will be a multicenter, prospective single-arm study planned to be conducted at Regional Ayurveda Research Institute, Thiruvananthapuram, Regional Ayurveda Research Institute Nagpur, National Ayurveda Research Institute for Panchakarma, Cheruturthy and Regional Ayurveda Research Institute Vijayawada. One hundred sixty participants will be recruited for the trial (40 from each center). In the dose of 6gm, SG will be administered twice daily with lukewarm water after food. Vaginal douche will be done with TK for seven days in two consecutive cycles. The primary outcome will be change in the quantity of white discharge using visual analog scale. The secondary outcome will be change in other associated symptoms like pruritis vulva, lower abdominal pain, low back ache, burning micturition, and dyspareunia using the Visual Analogue Scale; change in the Quality of life and well-being by PGWBI score; change in Score of Investigator’s Global Satisfaction Scale, and changes in Patient’s Global Satisfaction Scale from baseline to final visit. Clinical/biochemical assessments will determine the safety and tolerability of the formulation during the follow-ups. Compared with the baseline, the efficacy of interventions on the 84th and 98th day, will be assessed with Paired t-test. Data will be analyzed using SPSS 15.0 software. ETHICS AND DISSEMINATION: The IEC clearance has been obtained from each participating institute. After completion of the trial, the outcome will be disseminated through peer-reviewed journals for publication.
{"title":"Efficacy and safety evaluation of Shatavari Gudam and Triphala Kashaya in leucorrhoea (Shwetapradara) – A study protocol of an open-label, multicenter, interventional, single-arm trial","authors":"Savita Gopod, Sujata P. Dhoke, K. Anumol, P. Kumar, Soumya Sheji, Manisha Talekar, L. Sharma, Arunabh Tripathi, S. Ota","doi":"10.4103/jras.jras_168_22","DOIUrl":"https://doi.org/10.4103/jras.jras_168_22","url":null,"abstract":"BACKGROUND: In the classical text of Ayurveda, formulations Shatavari Gudam (SG) and Triphala Kashaya (TK) are indicated to treat Shwetapradara. The disease Shwetapradara can be correlated to leucorrhoea based on the similar symptom, painless, white-colored discharge from the vagina. SG is a formulation containing Shatavari (Asparagus racemosus) as a main ingredient. Several studies indicate Shatavari as a tonic for reproductive tract-related diseases. The external use of Triphala has anti-inflammatory, antiseptic, and anti-bacterial actions. The present article is a clinical study protocol on the efficacy and safety evaluation of SG and TK in leucorrhoea (Shwetapradara). MATERIALS AND METHODS: It will be a multicenter, prospective single-arm study planned to be conducted at Regional Ayurveda Research Institute, Thiruvananthapuram, Regional Ayurveda Research Institute Nagpur, National Ayurveda Research Institute for Panchakarma, Cheruturthy and Regional Ayurveda Research Institute Vijayawada. One hundred sixty participants will be recruited for the trial (40 from each center). In the dose of 6gm, SG will be administered twice daily with lukewarm water after food. Vaginal douche will be done with TK for seven days in two consecutive cycles. The primary outcome will be change in the quantity of white discharge using visual analog scale. The secondary outcome will be change in other associated symptoms like pruritis vulva, lower abdominal pain, low back ache, burning micturition, and dyspareunia using the Visual Analogue Scale; change in the Quality of life and well-being by PGWBI score; change in Score of Investigator’s Global Satisfaction Scale, and changes in Patient’s Global Satisfaction Scale from baseline to final visit. Clinical/biochemical assessments will determine the safety and tolerability of the formulation during the follow-ups. Compared with the baseline, the efficacy of interventions on the 84th and 98th day, will be assessed with Paired t-test. Data will be analyzed using SPSS 15.0 software. ETHICS AND DISSEMINATION: The IEC clearance has been obtained from each participating institute. After completion of the trial, the outcome will be disseminated through peer-reviewed journals for publication.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131001131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mann Ki Baat Inspiration: Reimagining India’s health system","authors":"B. Patwardhan","doi":"10.4103/jras.jras_98_23","DOIUrl":"https://doi.org/10.4103/jras.jras_98_23","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130644597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Narayanam Srikanth, Sophia Jameela, A. Rai, B. Rao, S. Khanduri, B. Yadav
{"title":"Research initiatives and network linkages in COVID-19: Neo-dynamics of R&D in the Ayush sector","authors":"Narayanam Srikanth, Sophia Jameela, A. Rai, B. Rao, S. Khanduri, B. Yadav","doi":"10.4103/jras.jras_77_23","DOIUrl":"https://doi.org/10.4103/jras.jras_77_23","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129972944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/jras.jras_154_22
Abhimanyu Kumar
In India, various healthcare systems are practiced, and every system is well-received by its citizens. Recently, the Government of India has planned to develop a “One Nation, One Health System” to offer a unified Health Care System with all the possible advantages of every system of medicine. Regarding such a plan, a well-designed Integrative Medicine Protocol for various diseases is the need of the hour. This approach to health care should be implemented after a thorough review of the situation, which may come across as a hurdle. A single healthcare system will allow for better outcomes and potentially improve the country’s quality of health care.
{"title":"Integrative medicine: A unified approach for the future medicine","authors":"Abhimanyu Kumar","doi":"10.4103/jras.jras_154_22","DOIUrl":"https://doi.org/10.4103/jras.jras_154_22","url":null,"abstract":"In India, various healthcare systems are practiced, and every system is well-received by its citizens. Recently, the Government of India has planned to develop a “One Nation, One Health System” to offer a unified Health Care System with all the possible advantages of every system of medicine. Regarding such a plan, a well-designed Integrative Medicine Protocol for various diseases is the need of the hour. This approach to health care should be implemented after a thorough review of the situation, which may come across as a hurdle. A single healthcare system will allow for better outcomes and potentially improve the country’s quality of health care.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"97 3-4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132193377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/jras.jras_148_22
C. Katiyar, Sunil Dubey
Convergence of Ayush/traditional medicines with modern medicines by bringing into effect integration of the two or more systems is the way forward for developing holistic healthcare systems throughout the country, based on the concept of the One Nation, One Health System. Adopting schemes, programs, and strategies for bringing about changes in the education system and medical practice, along with ensuring their implementation at each stratum, will aid in unifying the healthcare systems. Given the existence of medical pluralism in India, it is the need of the hour to amalgamate our ancient traditional knowledge and contemporary medicine to build a system wherein both work in unison to promote good health and confer protection from various diseases and make provision for their management in the best possible manner. The current article discusses the requirements and probable impact of developing such system.
{"title":"One Nation, One Health System integrative policy: Blending wisdom of ancient and contemporary health sciences","authors":"C. Katiyar, Sunil Dubey","doi":"10.4103/jras.jras_148_22","DOIUrl":"https://doi.org/10.4103/jras.jras_148_22","url":null,"abstract":"Convergence of Ayush/traditional medicines with modern medicines by bringing into effect integration of the two or more systems is the way forward for developing holistic healthcare systems throughout the country, based on the concept of the One Nation, One Health System. Adopting schemes, programs, and strategies for bringing about changes in the education system and medical practice, along with ensuring their implementation at each stratum, will aid in unifying the healthcare systems. Given the existence of medical pluralism in India, it is the need of the hour to amalgamate our ancient traditional knowledge and contemporary medicine to build a system wherein both work in unison to promote good health and confer protection from various diseases and make provision for their management in the best possible manner. The current article discusses the requirements and probable impact of developing such system.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130167032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/jras.jras_177_22
V. Kotecha
{"title":"Aligning collaboration and integration towards “One Nation, One Health System” for a resilient public health delivery","authors":"V. Kotecha","doi":"10.4103/jras.jras_177_22","DOIUrl":"https://doi.org/10.4103/jras.jras_177_22","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"231 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122773072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/jras.jras_166_22
SP Thyagarajan
The utilization of traditional knowledge is crucial for achieving universal healthcare, according to the World Health Organization (WHO) Traditional Medicine Strategy 2014–23. The Indian systems of Medicine—Ayurveda, Yoga, Unani, Siddha, and homeopathy (Ayush)—have been projected to play a significant role in universal healthcare due to the emphasis placed on preventive and promotive health, their reasonable cost, low level of technological input, and the rising popularity of naturally derived plant-based products. These systems are being recommended for inclusion in national public health policy. Traditional Medicine (TM) is being used more frequently, which has raised questions regarding its safety and toxicity potential, such as hepatotoxicity. Thus, under the Department of Ayush’s vision and mission-2030, it is intended to develop scientific evidence in Ayurvedic principles and drug therapies by integrating ancient wisdom with modern technology and to bring Ayurveda to the people through innovations related to diagnostics, preventive, promotive as well as treatment methods and introduce scientific research for sustained availability of quality natural resources, to translate them into practical applications as modern science solutions for ensuring international acceptance of Ayush systems and their integration into National Health System and Modern Medicine, achieving the goal of One Nation, One Health System. Ayurvedic biology, standardization through chemobiological fingerprinting, chemobiological assays, and Pharmacovigilance studies of herbal medicines are suggested.
{"title":"Integration of Ayush within national health care systems: Challenges and the way forward","authors":"SP Thyagarajan","doi":"10.4103/jras.jras_166_22","DOIUrl":"https://doi.org/10.4103/jras.jras_166_22","url":null,"abstract":"The utilization of traditional knowledge is crucial for achieving universal healthcare, according to the World Health Organization (WHO) Traditional Medicine Strategy 2014–23. The Indian systems of Medicine—Ayurveda, Yoga, Unani, Siddha, and homeopathy (Ayush)—have been projected to play a significant role in universal healthcare due to the emphasis placed on preventive and promotive health, their reasonable cost, low level of technological input, and the rising popularity of naturally derived plant-based products. These systems are being recommended for inclusion in national public health policy. Traditional Medicine (TM) is being used more frequently, which has raised questions regarding its safety and toxicity potential, such as hepatotoxicity. Thus, under the Department of Ayush’s vision and mission-2030, it is intended to develop scientific evidence in Ayurvedic principles and drug therapies by integrating ancient wisdom with modern technology and to bring Ayurveda to the people through innovations related to diagnostics, preventive, promotive as well as treatment methods and introduce scientific research for sustained availability of quality natural resources, to translate them into practical applications as modern science solutions for ensuring international acceptance of Ayush systems and their integration into National Health System and Modern Medicine, achieving the goal of One Nation, One Health System. Ayurvedic biology, standardization through chemobiological fingerprinting, chemobiological assays, and Pharmacovigilance studies of herbal medicines are suggested.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126006155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}